Evidence map›Paper›PMID 33758256›Full record

ArticleScientific reports2021

Selective time-dependent changes in activity and cell-specific gene expression in human postmortem brain.

Fabien Dachet, James B Brown, Tibor Valyi-Nagy, Kunwar D Narayan, Anna Serafini, Nathan Boley, Thomas R Gingeras, Susan E Celniker, Gayatry Mohapatra, Jeffrey A Loeb

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 2 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 2 syntheses or guidelines pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Brain and retina in Alzheimer's disease: Pathological intersections and estimates from imaging.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Fabien DachetUniversity of Illinois at Chicago, Chicago, IL, 60612, USA. fdachet@uic.edu.
James B BrownLawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA.
Tibor Valyi-NagyUniversity of Illinois at Chicago, Chicago, IL, 60612, USA.
Kunwar D NarayanUniversity of Illinois at Chicago, Chicago, IL, 60612, USA.
Anna SerafiniUniversity of Illinois at Chicago, Chicago, IL, 60612, USA.
Nathan BoleyUniversity of California, Berkeley, CA, 94720, USA.
Thomas R GingerasCold Spring Harbor Laboratory, Cold Spring Harbor, NY, 11724, USA.
Susan E CelnikerLawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA.
Gayatry MohapatraUniversity of Illinois at Chicago, Chicago, IL, 60612, USA.
Jeffrey A LoebUniversity of Illinois at Chicago, Chicago, IL, 60612, USA. jaloeb@uic.edu.
University of Illinois Chicago · USLawrence Berkeley National Laboratory · USCold Spring Harbor Laboratory · USUniversity of California, Berkeley · US

Funding

Single-Cell Biology Shared ResourceP30CA045508 · NCI · COLD SPRING HARBOR LABORATORY · PI John Edward Moses · 1987 to 2026
$118.9M
Strengthening Stakeholder Engagement in Human Research Protections.UL1TR002003 · NCATS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KARNIK, NIRANJAN SUBHASH, MERMELSTEIN, ROBIN J. · 2016 to 2024
$33.7M
Molecular and Cellular Basis of Spiking and Seizures in Neocortical EpilepsyR01NS109515 · NINDS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LOEB, JEFFREY A · 2019 to 2023
$2.3M
MAPK Signaling in Neocortical EpilepsyR56NS083527 · NINDS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LOEB, JEFFREY A · 2015 to 2015
$400k
NCATS NIH HHS UL1 TR002003NCI NIH HHS P30 CA045508NINDS NIH HHS R01 NS109515NINDS NIH HHS R56 NS083527
6 · The paper itself

Abstract

As a means to understand human neuropsychiatric disorders from human brain samples, we compared the transcription patterns and histological features of postmortem brain to fresh human neocortex isolated immediately following surgical removal. Compared to a number of neuropsychiatric disease-associated postmortem transcriptomes, the fresh human brain transcriptome had an entirely unique transcriptional pattern. To understand this difference, we measured genome-wide transcription as a function of time after fresh tissue removal to mimic the postmortem interval. Within a few hours, a selective reduction in the number of neuronal activity-dependent transcripts occurred with relative preservation of housekeeping genes commonly used as a reference for RNA normalization. Gene clustering indicated a rapid reduction in neuronal gene expression with a reciprocal time-dependent increase in astroglial and microglial gene expression that continued to increase for at least 24 h after tissue resection. Predicted transcriptional changes were confirmed histologically on the same tissue demonstrating that while neurons were degenerating, glial cells underwent an outgrowth of their processes. The rapid loss of neuronal genes and reciprocal expression of glial genes highlights highly dynamic transcriptional and cellular changes that occur during the postmortem interval. Understanding these time-dependent changes in gene expression in post mortem brain samples is critical for the interpretation of research studies on human brain disorders.

Indexed as

BiomarkersGene ExpressionAutopsyBrainComputational BiologyGene Expression ProfilingHumansImmunohistochemistryNeuronsOrgan SpecificityTranscriptomeBiomarkers

Identifiers

PMID33758256
PMCPMC7988150
OpenAlexW3139191888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.